| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Respiratory Medicine and Clinical Physiology (Drs. Eaton, Garrett, and Whitlock, and Mr. Withy), Green Lane Hospital, Auckland, New Zealand; and Department of General Medicine (Dr. Rea), Middlemore Hospital, Auckland, New Zealand.
Correspondence to: T. Eaton, MBChB, Department of Respiratory Services, Green Lane Hospital, Auckland 3, New Zealand
Objective: To determine the quality of spirometry performed in primary care practice and to assess the impact of formal training.
Design: Randomized, controlled prospective interventional study.
Setting: Primary care practice, Auckland City, New Zealand.
Participants: Thirty randomly selected primary care practices randomized to "trained" or "usual" groups. One doctor and one practice nurse were nominated to participate from each practice.
Interventions: "Trained" was defined as participation in an "initial" spirometry workshop at week 0 and a "maintenance of standards" workshop at week 12. "Usual" was defined as no formal training until week 12, when participants they attended the same "initial" workshop provided for the trained group. The study duration was 16 weeks. Each practice was provided with a spirometer to be used at their clinical discretion.
Measurements and results: Spirometry data were uploaded weekly and analyzed using American Thoracic Society (ATS) criteria for acceptability and reproducibility. The workshops were assessed objectively with practical and written assessments, confirming a significant training effect. However, analysis of spirometry performed in clinical practice by the trained practitioners revealed three acceptable blows in only 18.9% of patient tests. In comparison, 5.1% of patient tests performed by the usual practitioners had three acceptable blows (p < 0.0001). Only 13.5% of patient tests in the trained group and 3.4% in the usual group (p < 0.0001) satisfied full acceptability and reproducibility criteria. However, 33.1% and 12.5% of patient tests in the trained and usual groups, respectively (p < 0.0001), achieved at least two acceptable blows, the minimum requirement. Nonacceptability was largely ascribable to failure to satisfy end-of-test criteria; a blow of at least 6 s. Visual inspection of the results of these blows as registered on the spirometer for the presence of a plateau on the volume-time curve suggests that < 15% were acceptable.
Conclusions: Although a significant training effect was demonstrated, the quality of the spirometry performed in clinical practice did not generally satisfy full ATS criteria for acceptability and reproducibility. Further study would be required to determine the clinical impact. However, the ATS guidelines allow for the use of data from unacceptable or nonreproducible maneuvers at the discretion of the interpreter. Since most of the failures were end-of-test related, the FEV1 levels are likely to be valid. Our results serve to emphasize the importance of effective training and quality assurance programs to the provision of successful spirometry in primary care practice.
Key Words: primary care practice • quality assurance • randomized controlled • spirometry • spirometry workshops
This article has been cited by other articles:
|
|
 |
|
  B. P. Yawn, P. L. Enright, R. F. Lemanske Jr, E. Israel, W. Pace, P. Wollan, and H. Boushey Spirometry Can Be Done in Family Physicians' Offices and Alters Clinical Decisions in Management of Asthma and COPD Chest, October 1, 2007; 132(4): 1162 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Aggarwal, D. Gupta, and S. K. Jindal The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor. Chest, November 1, 2006; 130(5): 1454 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J P Poels, T. R J Schermer, C. van Weel, and P. M A Calverley Spirometry in chronic obstructive pulmonary disease. BMJ, October 28, 2006; 333(7574): 870 - 871. [Full Text] [PDF]
|
|
|
|
 |
|
 D M Mannino Spirometric screening: does it work? Thorax, October 1, 2006; 61(10): 834 - 835. [Full Text] [PDF]
|
|
|
|
|
|
G. Liistro, C. Vanwelde, W. Vincken, J. Vandevoorde, G. Verleden, J. Buffels, and on Behalf of the COPD Advisory Board Technical and functional assessment of 10 office spirometers: a multicenter comparative study. Chest, September 1, 2006; 130(3): 657 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Hansen, X-G. Sun, and K. Wasserman Should forced expiratory volume in six seconds replace forced vital capacity to detect airway obstruction? Eur. Respir. J., June 1, 2006; 27(6): 1244 - 1250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zielinski, M. Bednarek, D. Gorecka, G. Viegi, S. S. Hurd, Y. Fukuchi, C. K. W. Lai, P. X. Ran, F. W. S. Ko, S. M. Liu, et al. Increasing COPD awareness. Eur. Respir. J., April 1, 2006; 27(4): 833 - 852. [Full Text] [PDF]
|
|
|
|
|
|
M. Lusuardi, F. De Benedetto, P. Paggiaro, C. M. Sanguinetti, G. Brazzola, P. Ferri, and C. F. Donner A Randomized Controlled Trial on Office Spirometry in Asthma and COPD in Standard General Practice : Data From Spirometry in Asthma and COPD: a Comparative Evaluation Italian Study,{dagger}. Chest, April 1, 2006; 129(4): 844 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Pellegrino, M. Decramer, C. P. O. van Schayck, P. N. R. Dekhuijzen, T. Troosters, C. van Herwaarden, D. Olivieri, M. Del Donno, W. De Backer, I. Lankhorst, et al. Quality control of spirometry: a lesson from the BRONCUS trial Eur. Respir. J., December 1, 2005; 26(6): 1104 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zanconato, G. Meneghelli, R. Braga, F. Zacchello, E. Baraldi, and on behalf of the Working Group Office Spirometry in Primary Care Pediatrics: A Pilot Study Pediatrics, December 1, 2005; 116(6): e792 - e797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. C. Ioachimescu, S. B. Venkateshiah, M. S. Kavuru, K. McCarthy, and J. K. Stoller Estimating FVC From FEV2 and FEV3: Assessment of a Surrogate Spirometric Parameter Chest, September 1, 2005; 128(3): 1274 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B G Cooper Limitations to spirometry being performed in 'the office' Chronic Respiratory Disease, April 1, 2005; 2(2): 113 - 115. [PDF]
|
|
|
|
|
|
M Decramer, R Gosselink, M Rutten-Van Molken, J Buffels, O Van Schayck, P-A Gevenois, R Pellegrino, E Derom, and W De Backer Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004 Thorax, April 1, 2005; 60(4): 335 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Kaminsky Spirometry and Diabetes: Implications of reduced lung function Diabetes Care, March 1, 2004; 27(3): 837 - 838. [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, C. L. Emerman, R. K. Cydulka, B. H. Rowe, S. Clark, and C. A. Camargo Prospective Multicenter Study of Relapse Following Emergency Department Treatment of COPD Exacerbation Chest, February 1, 2004; 125(2): 473 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Schermer, T. Eaton, R. Pauwels, and C. van Weel Spirometry in primary care: is it good enough to face demands like World COPD Day? Eur. Respir. J., November 1, 2003; 22(5): 725 - 727. [Full Text] [PDF]
|
|
|
|
|
|
T R Schermer, J E Jacobs, N H Chavannes, J Hartman, H T Folgering, B J Bottema, and C van Weel Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) Thorax, October 1, 2003; 58(10): 861 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Golshan, M. Nematbakhsh, B. Amra, and R.O. Crapo Spirometric reference values in a large Middle Eastern population Eur. Respir. J., September 1, 2003; 22(3): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miravitlles, C. Murio, T. Guerrero, and R. Gisbert Costs of Chronic Bronchitis and COPD: A 1-Year Follow-up Study Chest, March 1, 2003; 123(3): 784 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Cerveri, A. Corsico, M. C. Zoia, J. Zielinski, and M. Bednarek COPD Screening in High-Risk Groups Chest, March 1, 2003; 123(3): 959 - 960. [Full Text] [PDF]
|
|
|
|
|
|
M. Miravitlles, C. Murio, T. Guerrero, and R. Gisbert Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD* Chest, May 1, 2002; 121(5): 1449 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Petty Commentary: Quality of Spirometry Testing American Journal of Medical Quality, November 1, 2001; 16(6): 216 - 218. [Abstract] [PDF]
|
|
|
|
|
|
M. Miravitlles, C. Murio, and T. Guerrero Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis Eur. Respir. J., May 1, 2001; 17(5): 928 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Ferguson, P. L. Enright, A. S. Buist, and M. W. Higgins Office Spirometry for Lung Health Assessment in Adults: A Consensus Statement From the National Lung Health Education Program Chest, April 1, 2000; 117(4): 1146 - 1161. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
